TSC2: filling the GAP in the mTOR signaling pathway.

[1]  R. Yeung.  Multiple roles of the tuberous sclerosis complex genes , 2003, Genes, chromosomes & cancer.

[2]  F. Tamanoi,et al.  Identification of Dominant Negative Mutants of Rheb GTPase and Their Use to Implicate the Involvement of Human Rheb in the Activation of p70S6K* , 2003, Journal of Biological Chemistry.

[3]  F. Tamanoi,et al.  Drosophila Rheb GTPase is required for cell cycle progression and cell growth , 2003, Journal of Cell Science.

[4]  A. F. Castro,et al.  Rheb Binds Tuberous Sclerosis Complex 2 (TSC2) and Promotes S6 Kinase Activation in a Rapamycin- and Farnesylation-dependent Manner* , 2003, Journal of Biological Chemistry.

[5]  J. Blenis,et al.  Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb , 2003, Current Biology.

[6]  K. Inoki,et al.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. , 2003, Genes & development.

[7]  S. Schreiber,et al.  Integration of growth factor and nutrient signaling: implications for cancer biology. , 2003, Molecular cell.

[8]  V. Krymskaya.  Tumour suppressors hamartin and tuberin: intracellular signalling. , 2003, Cellular signalling.

[9]  E. Hafen,et al.  Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.

[10]  E. Hafen,et al.  Rheb is an essential regulator of S6K in controlling cell growth in Drosophila , 2003, Nature Cell Biology.

[11]  B. Edgar,et al.  Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins , 2003, Nature Cell Biology.

[12]  B. Edgar,et al.  Rheb promotes cell growth as a component of the insulin/TOR signalling network , 2003, Nature Cell Biology.

[13]  M. Goedbloed,et al.  Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins. , 2003, Biochemical Society transactions.

[14]  K. Inoki,et al.  The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3* , 2003, The Journal of Biological Chemistry.

[15]  Paul Tempst,et al.  GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. , 2003, Molecular cell.

[16]  Y. Xiong,et al.  14-3-3β Binds to and Negatively Regulates the Tuberous Sclerosis Complex 2 (TSC2) Tumor Suppressor Gene Product, Tuberin* , 2003, The Journal of Biological Chemistry.

[17]  D. Kwiatkowski,et al.  Tuberous Sclerosis: from Tubers to mTOR , 2003, Annals of human genetics.

[18]  E. Henske,et al.  Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration , 2002, Oncogene.

[19]  Hongbing Zhang,et al.  Tsc2 Null Murine Neuroepithelial Cells Are a Model for Human Tuber Giant Cells, and Show Activation of an mTOR Pathway , 2002, Molecular and Cellular Neuroscience.

[20]  K. Inoki,et al.  Regulation of TSC2 by 14-3-3 Binding* , 2002, The Journal of Biological Chemistry.

[21]  Steven J. Marygold,et al.  Growth Signaling: TSC Takes Its Place , 2002, Current Biology.

[22]  Y. Nabeshima,et al.  Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system. , 2002, Human Molecular Genetics.

[23]  C. Walker,et al.  14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). , 2002, Cancer research.

[24]  C. Proud,et al.  Regulation of mammalian translation factors by nutrients. , 2002, European journal of biochemistry.

[25]  A. Hodges,et al.  Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent , 2002, The Journal of cell biology.

[26]  L. Aicher,et al.  Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. , 2002, Cancer research.

[27]  R. Abraham.  Identification of TOR Signaling Complexes More TORC for the Cell Growth Engine , 2002, Cell.

[28]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Nicosia,et al.  Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.

[30]  P. Worley,et al.  Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells , 2002, Oncogene.

[31]  O. Hino,et al.  Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling , 2002, Nature Cell Biology.

[32]  D. Alessi,et al.  TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.

[33]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[34]  D. Kwiatkowski,et al.  Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation , 2002, The Journal of Biological Chemistry.

[35]  Channing J Der,et al.  Farnesyltransferase inhibitors: promises and realities. , 2002, Current opinion in pharmacology.

[36]  J. Avruch,et al.  Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.

[37]  A. Hall,et al.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.

[38]  Tomohiro Matsumoto,et al.  Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombe. , 2002, Genetics.

[39]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[40]  Gideon Bollag,et al.  GTPase activating proteins: critical regulators of intracellular signaling. , 2002, Biochimica et biophysica acta.

[41]  Hongbing Zhang,et al.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. , 2002, Human molecular genetics.

[42]  A. V. D. van den Ouweland,et al.  TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. , 2001, Human molecular genetics.

[43]  A. Hodges,et al.  Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin. , 2001, Human molecular genetics.

[44]  J. Urano,et al.  Failure to farnesylate Rheb protein contributes to the enrichment of G0/G1 phase cells in the Schizosaccharomyces pombe farnesyltransferase mutant , 2001, Molecular microbiology.

[45]  Tetsuo Noda,et al.  A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Hengstschläger,et al.  Tuberous sclerosis gene products in proliferation control. , 2001, Mutation research.

[47]  Xinsheng Gao,et al.  TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. , 2001, Genes & development.

[48]  C. Potter,et al.  Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size , 2001, Cell.

[49]  B. Dickson,et al.  The Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation , 2001, Cell.

[50]  G. Landes,et al.  Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. , 2001, Molecular cell.

[51]  J. Heitman,et al.  The TOR Kinases Link Nutrient Sensing to Cell Growth* , 2001, The Journal of Biological Chemistry.

[52]  G. Rubin,et al.  gigas , a Drosophila Homolog of Tuberous Sclerosis Gene Product-2, Regulates the Cell Cycle , 1999, Cell.

[53]  J. Urano,et al.  Characterization of Rheb functions using yeast and mammalian systems. , 2001, Methods in enzymology.

[54]  J Otlewski,et al.  Structure of small G proteins and their regulators. , 2001, Acta biochimica Polonica.

[55]  G. Benvenuto,et al.  The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination , 2000, Oncogene.

[56]  Tobias Schmelzle,et al.  TOR, a Central Controller of Cell Growth , 2000, Cell.

[57]  D. Kwiatkowski,et al.  Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.

[58]  K. Furge,et al.  Loss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation. , 2000, Genetics.

[59]  H. Vinters,et al.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho , 2000, Nature Cell Biology.

[60]  H. Moses,et al.  Farnesyltransferase Inhibitor Induces Rapid Growth Arrest and Blocks p70s6k Activation by Multiple Stimuli* , 2000, The Journal of Biological Chemistry.

[61]  S. Sparagana,et al.  Tuberous sclerosis complex. , 2000, Current opinion in neurology.

[62]  G. Thomas,et al.  Ribosomal S6 kinase signaling and the control of translation. , 1999, Experimental cell research.

[63]  J. Cherfils,et al.  GEFs: structural basis for their activation of small GTP-binding proteins. , 1999, Trends in biochemical sciences.

[64]  S. Snyder,et al.  Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. , 1999, Science.

[65]  S Povey,et al.  The genetic basis of tuberous sclerosis. , 1998, Molecular medicine today.

[66]  A. Wittinghofer,et al.  GTPase-activating proteins: helping hands to complement an active site. , 1998, Trends in biochemical sciences.

[67]  R. Snell,et al.  Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.

[68]  P. Harris,et al.  The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. , 1997, Human molecular genetics.

[69]  W. Kabsch,et al.  The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.

[70]  C. Der,et al.  The Ras-related Protein Rheb Is Farnesylated and Antagonizes Ras Signaling and Transformation* , 1997, The Journal of Biological Chemistry.

[71]  E. Golemis,et al.  The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.

[72]  P. Worley,et al.  Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals , 1997, Molecular and cellular biology.

[73]  P. Casey,et al.  Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.

[74]  R. Sandford,et al.  Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. , 1996, Human molecular genetics.

[75]  J. Declue,et al.  Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.

[76]  C. Barnes,et al.  rheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein. , 1994, The Journal of biological chemistry.

[77]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.